Sterling Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$715K Hold
777
0.21% 58
2025
Q4
$835K Sell
777
-7
-0.9% -$6.69K 0.25% 56
2025
Q3
$598K Hold
784
0.19% 65
2025
Q2
$611K Sell
784
-14
-2% -$10.9K 0.2% 63
2025
Q1
$659K Buy
798
+32
+4% +$26.6K 0.24% 58
2024
Q4
$591K Sell
766
-39
-5% -$32.3K 0.22% 63
2024
Q3
$713K Sell
805
-39
-5% -$35.1K 0.26% 57
2024
Q2
$764K Sell
844
-19
-2% -$15.2K 0.31% 55
2024
Q1
$671K Buy
863
+6
+0.7% +$4.27K 0.27% 58
2023
Q4
$500K Buy
857
+20
+2% +$11.7K 0.22% 68
2023
Q3
$450K Hold
837
0.23% 66
2023
Q2
$393K Hold
837
0.19% 71
2023
Q1
$287K Hold
837
0.16% 78
2022
Q4
$306K Sell
837
-14
-2% -$4.96K 0.18% 76
2022
Q3
$275K Hold
851
0.19% 74
2022
Q2
$276K Hold
851
0.19% 74
2022
Q1
$244K Hold
851
0.15% 84
2021
Q4
$235K Hold
851
0.15% 86
2021
Q3
$197K Sell
851
-95
-10% -$23.4K 0.13% 87
2021
Q2
$217K Hold
946
0.14% 79
2021
Q1
$177K Hold
946
0.13% 83
2020
Q4
$160K Buy
+946
New +$141K 0.13% 84

Other funds holding LLY

Sterling Financial Planning's LLY Position: Q1 2026 in Review

Sterling Financial Planning held its Eli Lilly (LLY) position steady in Q1 2026 at 777 shares worth $715K. The position accounts for 0.21% of the portfolio, ranked #58.

Sterling Financial Planning first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $835K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sterling Financial Planning held 777 shares of Eli Lilly worth $715K as of Q1 2026.
  • Sterling Financial Planning left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.21% of Sterling Financial Planning's portfolio in Q1 2026, its #58 holding.
  • Sterling Financial Planning first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Sterling Financial Planning's Eli Lilly position peaked at $835K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sterling Financial Planning's 13F filing for Q1 2026, filed 6 May 2026.